212 related articles for article (PubMed ID: 28220235)
1. Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.
Hackl A; Ehren R; Kirschfink M; Zipfel PF; Beck BB; Weber LT; Habbig S
Pediatr Nephrol; 2017 Jun; 32(6):1081-1087. PubMed ID: 28220235
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of DEAP-HUS with eculizumab.
Noone D; Waters A; Pluthero FG; Geary DF; Kirschfink M; Zipfel PF; Licht C
Pediatr Nephrol; 2014 May; 29(5):841-51. PubMed ID: 24249282
[TBL] [Abstract][Full Text] [Related]
3. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
Sinha A; Gulati A; Saini S; Blanc C; Gupta A; Gurjar BS; Saini H; Kotresh ST; Ali U; Bhatia D; Ohri A; Kumar M; Agarwal I; Gulati S; Anand K; Vijayakumar M; Sinha R; Sethi S; Salmona M; George A; Bal V; Singh G; Dinda AK; Hari P; Rath S; Dragon-Durey MA; Bagga A;
Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
[TBL] [Abstract][Full Text] [Related]
4. The autoimmune disease DEAP-hemolytic uremic syndrome.
Skerka C; Zipfel PF; Müller D; Micklisch S; Riedl M; Zimmerhackl LB; Hofer J
Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
[TBL] [Abstract][Full Text] [Related]
5. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.
Zipfel PF; Mache C; Müller D; Licht C; Wigger M; Skerka C;
Pediatr Nephrol; 2010 Oct; 25(10):2009-19. PubMed ID: 20157737
[TBL] [Abstract][Full Text] [Related]
6. Atypical hemolytic uremic syndrome due to factor H autoantibody.
Uslu-Gökceoğlu A; Doğan CS; Comak E; Koyun M; Akman S
Turk J Pediatr; 2013; 55(1):86-9. PubMed ID: 23692839
[TBL] [Abstract][Full Text] [Related]
7. Pediatric atypical hemolytic-uremic syndrome due to auto-antibodies against factor H: is there an interest to combine eculizumab and mycophenolate mofetil?
Matrat L; Bacchetta J; Ranchin B; Tanné C; Sellier-Leclerc AL
Pediatr Nephrol; 2021 Jun; 36(6):1647-1650. PubMed ID: 33774745
[TBL] [Abstract][Full Text] [Related]
8. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
Dragon-Durey MA; Blanc C; Garnier A; Hofer J; Sethi SK; Zimmerhackl LB
Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
[TBL] [Abstract][Full Text] [Related]
9. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
Józsi M; Licht C; Strobel S; Zipfel SL; Richter H; Heinen S; Zipfel PF; Skerka C
Blood; 2008 Feb; 111(3):1512-4. PubMed ID: 18006700
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
11. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.
Waters AM; Pappworth I; Marchbank K; Bockenhauer D; Tullus K; Pickering MC; Strain L; Sebire N; Shroff R; Marks SD; Goodship TH; Rees L
Am J Transplant; 2010 Jan; 10(1):168-72. PubMed ID: 19951285
[TBL] [Abstract][Full Text] [Related]
12. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
Brocklebank V; Johnson S; Sheerin TP; Marks SD; Gilbert RD; Tyerman K; Kinoshita M; Awan A; Kaur A; Webb N; Hegde S; Finlay E; Fitzpatrick M; Walsh PR; Wong EKS; Booth C; Kerecuk L; Salama AD; Almond M; Inward C; Goodship TH; Sheerin NS; Marchbank KJ; Kavanagh D
Kidney Int; 2017 Nov; 92(5):1261-1271. PubMed ID: 28750931
[TBL] [Abstract][Full Text] [Related]
13. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
14. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
[TBL] [Abstract][Full Text] [Related]
15. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Guo WY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2017 May; 32(5):811-822. PubMed ID: 28035470
[TBL] [Abstract][Full Text] [Related]
16. Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal P; Gupta A; Sinha A; Saini S; Hari P; Dragon Durey MA; Bagga A
Pediatr Nephrol; 2015 Mar; 30(3):451-7. PubMed ID: 25217328
[TBL] [Abstract][Full Text] [Related]
17. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
Tran H; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of children with anti-CFH autoantibody-associated hemolytic uremic syndrome: a report of 8 cases.
Li Q; Kong X; Tian M; Wang J; Yang Z; Yu L; Liu S; Wang C; Wang X; Sun S
Ren Fail; 2022 Dec; 44(1):1061-1069. PubMed ID: 35730179
[TBL] [Abstract][Full Text] [Related]
19. The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.
Kim JJ; McCulloch M; Marks SD; Waters A; Noone D
Clin Nephrol; 2015 Jan; 83(1):49-56. PubMed ID: 24131678
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
